(Q37309247)

19 August 2017

1 reference

title

Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors (English)

1 reference

pattern recognition receptors

19 August 2017

1 reference

1 reference

1 reference

Szilvia Benko

1

1 reference

19 August 2017

Zoltán Magyarics

series ordinal

2

1 reference

19 August 2017

Attila Szabó

series ordinal

3

1 reference

19 August 2017

Eva Rajnavölgyi

series ordinal

4

1 reference

19 August 2017

1 May 2008

1 reference

19 August 2017

1 reference

19 August 2017

389

1 reference

19 August 2017

5

1 reference

19 August 2017

469-485

1 reference

Toll-like receptor signalling

19 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Host-range restriction of vaccinia virus E3L-specific deletion mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Regulation of phagosome maturation by signals from toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Regulation of IL-17 production in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

TLR pathways and IFN-regulatory factors: to each its own.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

C-type lectin receptors on dendritic cells and Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Improving vaccines by incorporating immunological coadjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Nod-like proteins in immunity, inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Targeting dendritic cells for priming cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cross-presentation, dendritic cells, tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Interleukin 1 plays a major role in the development of Th2-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Viruses know it all: new insights into IFN networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Antigen crosspresentation by human plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Phagosomes are competent organelles for antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Innate immune recognition of, and regulation by, DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Promotion of B cell immune responses via an alum-induced myeloid cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Toll-like receptors as adjuvant receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cell type-specific involvement of RIG-I in antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

NACHT-LRR proteins (NLRs) in bacterial infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Sensing of bacteria: NOD a lonely job

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Autophagy-dependent viral recognition by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

[Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes].

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

IFNalpha regulates NK cell cytotoxicity through STAT1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Immune tolerance after delivery of dying cells to dendritic cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Interferon regulatory factors: the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

NLRs join TLRs as innate sensors of pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Langerhans cells are the major source of mRNA for IL-1 beta and MIP-1 alpha among unstimulated mouse epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Modulating toll-like receptor signalling as a novel antiinfective approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Connecting mitochondria and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Langerhans cells renew in the skin throughout life under steady-state conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The RIP kinases: crucial integrators of cellular stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cross-presentation by intercellular peptide transfer through gap junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cationic microparticles are a potent delivery system for a HCV DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The inflammasome: a danger sensing complex triggering innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cross-presentation: underlying mechanisms and role in immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Langerhans cells - dendritic cells of the epidermis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Plasmacytoid dendritic cells: the key to CpG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Steady-state and inflammatory dendritic-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Recent advances in veterinary vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Immunomodulating and antiviral activities of the imidazoquinoline S-28463.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Cell biology of antigen processing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

NALPs: a novel protein family involved in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Current approaches in dendritic cell generation and future implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The uses of poxviruses as vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Marker rescue of the host range restriction defects of modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

TIR domain-containing adaptors define the specificity of TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Nod1-Mediated Innate Immune Recognition of Peptidoglycan Contributes to the Onset of Adaptive Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Synergistic enhancement of Toll-like receptor responses by NOD1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Toll-dependent selection of microbial antigens for presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

Bacterial DNA causes septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.054

21 January 2018

Identifiers

DOI

10.1515/BC.2008.054

1 reference

19 August 2017

1 reference